Gene · 3140
Papers1,845
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,845
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of the TCRβ repertoire of peripheral MR1-restricted MAIT cells in psoriasis vulgaris patients. | Sci Rep | 2023 | 38017021 | PubTator, text mining | PubMed |
| Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | 38008741 | PubTator, text mining | PubMed |
| Current Perspectives and Challenges of MAIT Cell-Directed Therapy for Tuberculosis Infection. | Pathogens | 2023 | 38003807 | PubTator, text mining | PubMed |
| Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease. | Nat Commun | 2023 | 37968302 | PubTator, text mining | PubMed |
| Mechanisms of liver fibrosis in metabolic syndrome. | eGastroenterology | 2023 | 37946713 | PubTator, text mining | PubMed |
| [A case of a pathological variant of the PRRT2 gene in twins with paroxysmal kinesiogenic dyskinesia]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2023 | 37942977 | PubTator, text mining | PubMed |
| Exploration of the shared genetic biomarkers in Alzheimer's disease and chronic kidney disease using integrated bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37933012 | PubTator, text mining | PubMed |
| Colonic mucosal associated invariant T cells in Crohn's disease have a diverse and non-public T cell receptor beta chain repertoire. | PLoS One | 2023 | 37922286 | PubTator, text mining | PubMed |
| Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. | Cancer Commun (Lond) | 2023 | 37920878 | PubTator, text mining | PubMed |
| Both Horatio and Polonius: Innate Lymphoid Cells in Tissue Homeostasis and Repair. | Immunohorizons | 2023 | 37916861 | PubTator, text mining | PubMed |
| Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. | Int J Mol Sci | 2023 | 37894816 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| MAIT cells altered phenotype and cytotoxicity in lupus patients are linked to renal disease severity and outcome. | Front Immunol | 2023 | 37885889 | PubTator, text mining | PubMed |
Analysis of Potential Risk Factors for Cement Leakage into Paraspinal Veins after Vertebroplasty for Acute Osteoporotic Vertebral Fractures Based on a 3D Reconstruction Technique: A Retrospective Matched Case-Control Study. | Orthop Surg | 2023 | 37880194 | PubTator, text mining | PubMed |
| Tumor immunology meets oncology (TIMO) XVII, April 20-22 2023 in Halle/Saale, Germany. | Cancer Immunol Immunother | 2023 | 37872395 | PubTator, text mining | PubMed |
| Unconventional T cells in brain homeostasis, injury and neurodegeneration. | Front Immunol | 2023 | 37854609 | PubTator, text mining | PubMed |
| Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance. | Redox Biol | 2023 | 37839356 | PubTator, text mining | PubMed |
| Monitoring regulatory T cells as a prognostic marker in lung transplantation. | Front Immunol | 2023 | 37818354 | PubTator, text mining | PubMed |
| Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis. | Nat Microbiol | 2023 | 37814073 | PubTator, text mining | PubMed |
| Retracted: Silencing MR-1 Protects against Myocardial Injury Induced by Chronic Intermittent Hypoxia by Targeting Nrf2 through Antioxidant Stress and Anti-Inflammation Pathways. | J Healthc Eng | 2023 | 37772013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3140/papers?page=10